Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats
[10] People With Pancreatic Diseases People with a history of pancreatitis or pancreatic cancer should avoid GLP-1 receptor agonists
Colton Jones, MD, the lead researcher and a hematology and medical oncology fellow at the University of Texas at San Antonio, and colleagues analyzed the health records of nearly 8,800 people with breast cancer and obesity taking both hormonal therapy and GLP-1s
Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures
Frequently asked questions How long does a single tirzepatide injection last
Naltrexone blocks opioid receptors in the hypothalamus, while bupropion, an antidepressant, increases dopamine and norepinephrine signaling